MyCelx Technologies Corporation Successful Trial of PFAS Remediation System (4558Z)
January 25 2022 - 2:00AM
UK Regulatory
TIDMMYX TIDMTTM
RNS Number : 4558Z
MyCelx Technologies Corporation
25 January 2022
25 January 2022
MYCELX Technologies Corporation
Successful Trial of MYCELX's PFAS Remediation System
Reduction to non-detect levels highlights significant commercial
opportunity
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the
clean water and clean air technology company, is pleased to
announce that it has successfully completed a trial in the United
States of its PFAS remediation system which deploys its patented
MYCELX technology. The results of the trial confirm the ability of
MYCELX's PFAS remediation system to reduce contamination to
non-detect level in a single pass through the system.
PFAS, which stands for perfluoroakyl and polyfluoroalkyl
compounds, are a collection of long-lasting man-made toxic
chemicals, which present a threat to the environment and human
health. The Company estimates the annual PFAS remediation cost in
the United States to be in excess of US$8bn.
As part of its continuing strategy to address the PFAS
remediation market, MYCELX commenced an important trial at an
industrial site in Newburgh, New York, in December 2021. The trial
involved treating PFAS contaminated water from a storm water
retention pond. The likely source of the PFAS contamination was
aqueous film forming foams (AFFF). The presence of additional
contaminants, such as glycols from plane de-icing procedures,
ensured a challenging and complex water source to remediate. MYCELX
installed a mobile trial system using the patented MYCELX
technology for PFAS remediation. Earlier generations of this
technology have already been successfully deployed in Australia,
which is recognised as being at the forefront of PFAS remediation.
The MYCELX solution is designed to offer a lower life-cycle cost of
treatment, primarily due to significantly reduced waste versus
alternative technologies.
The trial successfully demonstrated the ability of the MYCELX
system to completely remove all detected chemicals to
non-detectable concentrations in a single pass, achieving a 99.99%
removal efficiency. Complete removal of this spectrum of PFAS
chemicals eliminates both regulated PFAS compounds, and complete
removal will prevent future degradation of components into PFAS
compounds that may be subject to future regulation. The technology
provided a failsafe treatment with no rise in differential
pressures or increase in outlet concentrations over the length of
the trial.
Given the outlook for an increasingly strict regulatory climate
for PFAS contamination in North America, MYCELX, which was recently
awarded the Green Economy Mark by the London Stock Exchange for its
contribution to the global green economy, believes it is well
placed to play an important role in the global PFAS remediation
challenge.
Connie Mixon, CEO of MYCELX, said:
"I am delighted to announce a successful outcome at our trial in
the United States, which further proves the viability of our PFAS
remediation system, and will pave the way for our entry into the US
market. Our expansion in Australia continues to gather momentum,
with MYCELX technology currently deployed in five commercial
operations ranging from airports to military bases and with a
global oil supermajor.
With reliable and complete remediation of detectable PFAS
chemicals, MYCELX provides a breakthrough technological solution to
remove a complete range of PFAS types to below detectable levels.
We believe this means that the Company's offering not only has a
significant technical advantage over its competitors, but at a more
cost-effective price point. This test result is an important step
forward in progressing towards our first commercial contract for
PFAS remediation in the United States."
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity, Nominated Adviser
Henry Fitzgerald-O'Connor Tel: + 44 20 7523 8000
Georgina McCooke
Celicourt
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
The relevant notifications set out below are provided in
accordance with the requirements of Article 19 of the EU Market
Abuse Regulation (No. 596/2014).
Notes to Editors
Through its revolutionary oil-free water technology, MYCELX
brings its customers material benefits in terms of performance
enhancement, cost savings and significantly improved environmental
footprints. Working beyond any ordinary filtration methods,
MYCELX's proprietary technology achieves oil removal to less than
one part per million. MYCELX supports leading international
customers across the oil & gas value chain, as well as other
industrial users. MYCELX also provides advanced air filtration
technology for manufacturing and industrial facilities, effectively
removing oil particles and biologicals to maintain continuous and
safe air quality levels.
For more information, visit www.MYCELX.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
STRUSUURUUUAUUR
(END) Dow Jones Newswires
January 25, 2022 02:00 ET (07:00 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024